|
Ajanta Pharma Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
39687.07 Cr.
|
P/BV
|
8.65
|
Book Value (Rs.)
|
367.35
|
|
52 Week High/Low (Rs.)
|
3290/2330
|
FV/ML
|
2/1
|
P/E(X)
|
37.58
|
|
Bookclosure
|
10/11/2025
|
EPS (Rs.)
|
84.54
|
Div Yield (%)
|
0.88
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 84.53 | 73.56 | 64.82 | 45.89 | 82.45 |
| Diluted EPS (Rs.) | 84.51 | 73.53 | 64.77 | 45.89 | 82.45 |
| Cash EPS (Rs.) | 98.06 | 84.92 | 75.31 | 56.89 | 97.61 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 361.16 | 302.38 | 282.34 | 268.14 | 380.24 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 361.16 | 302.38 | 282.34 | 268.14 | 380.24 |
| Revenue From Operations / Share (Rs.) | 435.01 | 370.81 | 333.10 | 296.21 | 389.17 |
| PBDIT / Share (Rs.) | 125.00 | 108.02 | 99.45 | 69.80 | 121.72 |
| PBIT / Share (Rs.) | 111.19 | 96.52 | 88.73 | 59.45 | 107.13 |
| PBT / Share (Rs.) | 109.90 | 94.87 | 88.16 | 58.98 | 105.94 |
| Net Profit / Share (Rs.) | 84.24 | 73.43 | 64.60 | 46.54 | 83.01 |
| NP After MI And SOA / Share (Rs.) | 84.24 | 73.43 | 64.60 | 46.54 | 83.01 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 28.73 | 29.13 | 29.85 | 23.56 | 31.27 |
| PBIT Margin (%) | 25.56 | 26.02 | 26.63 | 20.06 | 27.52 |
| PBT Margin (%) | 25.26 | 25.58 | 26.46 | 19.91 | 27.22 |
| Net Profit Margin (%) | 19.36 | 19.80 | 19.39 | 15.71 | 21.33 |
| NP After MI And SOA Margin (%) | 19.36 | 19.80 | 19.39 | 15.71 | 21.33 |
| Return on Networth / Equity (%) | 23.32 | 24.28 | 22.87 | 17.35 | 21.83 |
| Return on Capital Employeed (%) | 29.40 | 30.10 | 29.95 | 21.21 | 26.98 |
| Return On Assets (%) | 17.15 | 18.35 | 17.59 | 12.56 | 17.57 |
| Total Debt / Equity (X) | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.97 | 0.96 | 0.90 | 0.81 | 0.83 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 2.64 | 2.85 | 3.05 | 2.49 | 3.50 |
| Quick Ratio (X) | 1.98 | 1.95 | 2.12 | 1.77 | 2.28 |
| Inventory Turnover Ratio (X) | 5.92 | 5.37 | 1.14 | 1.19 | 1.10 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 38.00 | 78.68 | 15.25 | 11.53 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 32.85 | 67.48 | 12.47 | 9.81 |
| Earning Retention Ratio (%) | 0.00 | 62.00 | 21.32 | 84.75 | 88.47 |
| Cash Earning Retention Ratio (%) | 0.00 | 67.15 | 32.52 | 87.53 | 90.19 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 97.26 | 65.32 | 174.28 | 151.01 | 102.45 |
| Interest Coverage Ratio (Post Tax) (%) | 66.55 | 45.40 | 114.20 | 101.68 | 70.87 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 35249.09 | 32649.25 | 28149.11 | 14945.61 | 15321.67 |
| EV / Net Operating Revenue (X) | 6.46 | 7.02 | 6.69 | 3.99 | 4.59 |
| EV / EBITDA (X) | 22.50 | 24.11 | 22.40 | 16.95 | 14.66 |
| MarketCap / Net Operating Revenue (X) | 6.44 | 7.06 | 6.72 | 4.08 | 4.65 |
| Retention Ratios (%) | 0.00 | 61.99 | 21.31 | 84.74 | 88.46 |
| Price / BV (X) | 7.76 | 8.66 | 7.93 | 4.51 | 4.76 |
| Price / Net Operating Revenue (X) | 6.44 | 7.06 | 6.72 | 4.08 | 4.65 |
| EarningsYield | 0.03 | 0.02 | 0.02 | 0.03 | 0.04 |
